Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Clinical trial NCT02221271 · COMPLETED

Trial details

NCT number: NCT02221271
Sponsor: Nihon Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Guillain-Barré Syndrome

Start date: 2014-10-01
Primary completion: 2015-08-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.